Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Laboratoires DELBERT
Deal Size : Undisclosed
Deal Type : Acquisition
Details : With the acquisition of Teralithe 250mg, divisible tablet and Teralithe LP 400mg, prolonged-release tablet (lithium carbonate), by Laboratoires DELBERT reinforces the strategy to ensure safe and continuous availability of Medications to patients and rein...
Brand Name : Teralithe
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 25, 2022
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Laboratoires DELBERT
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?